Viewing Company Centric Health | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Centric Health Stock Symbol: CHH-T

Last Price Recorded: $0.7200 on 2017-05-29

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-04-26 COMMENT Bruce Campbell (2)

There is a lot of room for them to grow on 2 fronts. They look after prescriptions for a long-term care facility and get paid a dispensing fee for that. From that perspective, they have lots of room to grow. They have a relationship with McKesson, which bought Rexall, and it was thought that they would get some of those contracts from McKesson which would increase their earnings and cash flow. The other side of the business is their surgical centres and are looking to increase the usage so they would be much more profitable.


Price:
$0.810
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Unknown
2017-03-10 COMMENT Bruce Campbell (2)

Just reported earnings and the stock had a pretty dramatic selloff, especially based on the numbers. This has transitioned in that they’ve had higher revenue and earnings numbers, as well as higher margins. Feels the market got a little disappointed in the growth rate, but the company has actually said that it is going to be November before the transition from Riviera beds to Chartwell beds ends. The big catalyst to watch is the debt refinancing. They’ve stated they are 80% along with a major Canadian bank. That will be a huge savings for them. He added to his holdings on the last selloff.


Price:
$0.720
Subject:
CANADIAN & CANNABIS STOCKS
Bias:
OPTIMISTIC
Owned:
Yes
2017-02-16 TOP PICK Fabrice Taylor

One division does private surgeries that are not covered by healthcare.  Every year they cut more and more services from provincial plans so there are more and more opportunities to use their services.  The other division is an industrial pharmacy that services businesses like seniors homes.  It is a turnaround story.  They used to have a lot of debt, but margins have improved.  He is impressed with management.  The stock has positive tailwinds and it is a turnaround story.  (Analysts’ target: $1.02).


Price:
$0.790
Subject:
NORTH AMERICAN
Bias:
SELECTIVE
Owned:
Yes
2017-01-25 TOP PICK Bruce Campbell (2)

Feels there is a fair bit of catalyst on this. They have 2 parts to the business, a specialty pharmacy and some surgical centres. The specialty pharmacies are basically pharmacies for long-term care facilities. They have a contract with a long-term care facility, and get paid to basically package prescriptions up for them and get paid a dispensing fee. Have about 27,000 beds right now, and he can see another 20,000 beds coming in. (Analysts’ price target is $0.80.)


Price:
$0.640
Subject:
CANADIAN
Bias:
BULLISH
Owned:
Yes
2015-03-11 COMMENT Bruce Campbell (2)

As far as the sector goes, they are in the right spot. Have just started to do more M&A and changing their business a little. He is watching this, but has other healthcare holdings that he likes better. Valuation is pretty good, and depending on what management does, there could be some potential for it to move higher.


Price:
$0.390
Subject:
CANADIAN SMALL & MIDCAPS
Bias:
UNKNOWN
Owned:
No
2012-10-12 SELL Jeff Parent B. Eng. FCSI

Cut your losses. $.71 is the floor and it broke through there.


Price:
$0.650
Subject:
TECHNICAL ANALYSIS
Bias:
BULL on ENERGY
Owned:
Unknown
2012-06-18 DON'T BUY Jason Donville CEO recently resigned and the last couple of quarters have been a disaster. There is a new management team. Grows by acquisition but doesn't think current management team can handle the strategy. Expect there will be more changes in the management team.
Price:
$0.850
Subject:
CANADIAN SMALL & FINANCIALS
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
No
Showing 1 to 7 of 7 entries

No Comments.


You must be logged in to comment.